Regeneron Pharmaceuticals
REGN
REGN
904 hedge funds and large institutions have $51.6B invested in Regeneron Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 102 funds opening new positions, 370 increasing their positions, 312 reducing their positions, and 118 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
11% less capital invested
Capital invested by funds: $57.9B → $51.6B (-$6.29B)
14% less first-time investments, than exits
New positions opened: 102 | Existing positions closed: 118
32% less funds holding in top 10
Funds holding in top 10: 25 → 17 (-8)
Holders
904
Holding in Top 10
17
Calls
$901M
Puts
$921M
Top Buyers
| 1 | +$143M | |
| 2 | +$132M | |
| 3 | +$102M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$80.2M |
| 5 |
HM
HealthCor Management
New York
|
+$74.9M |
Top Sellers
| 1 | -$314M | |
| 2 | -$163M | |
| 3 | -$156M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$117M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$104M |